Compliance Congress for Specialty Products
Specialty pharmaceutical companies face significant regulatory and industry barriers while attempting to provide therapies for rare, complex, or orphan diseases. [...]
Syndicated Report: Pharmacovigilance Software Market Is Booming Worldwide : Oracle, EXTEDO, Ab Cube
Ensuring drug safety and patient health requires an efficient and robust pharmacovigilance software platform. As a result, the global market [...]
Takeda’s Ramona Sequeira and Julie Kim Talk Research and Representation
Women are substantially underrepresented in biotech and pharma, even moreso in executive positions. In a new biospace article, Abbey Glasure [...]
Synklino Nets €29.8M Series A Funding for Cytomegalovirus Drug Trial
Synklino, a Danish biotech, announced on Monday, June 6th, that it received €29.8 in a Series A funding round for [...]
IDN & Bio/Pharma Partnering Summit | August 16-17, 2022 | Hybrid Event – Philadelphia, PA
Integrated delivery networks (IDNs) are a staple of the healthcare industry, but communication between them and bio/pharma firms is lacking. [...]
Syndicated Report: Cell and Gene Therapy Global Market Report 2022
The worldwide cell and gene therapy (CGT) market is set to grow over the next few years, with a projected [...]
Transparency, Aggregate Spend & HCP Engagement 2022 – August 9th-11th
Taking place in McClean, VA, the 2022 Transparency, Aggregate Spend & HCP Engagement conference will bring together compliance and legal [...]
Life Science Leaders Interview: Diversity & Inclusion Through The Eyes Of Two Female Pharma Executives
Companies in all markets have ramped up their diversity, equity, and inclusion (DEI) efforts in recent years. In the new [...]
Astorg Makes Deal with Amulet Capital Partners to Acquire OPEN Health
Astorg has announced that it will acquire OPEN Health from Amulet Capital Partners. OPEN Health, headquartered in London, UK, is [...]
Takeda CEO Signals Global Crises Could Force Drugmakers to Lower Prices
In a letter to shareholders sent Tuesday, May 31st, Takeda CEO Christophe Weber said that the escalating series of global [...]
Catalyst Shareholders Say $60 Million Vertex Deal Could’ve Happened in 2019
Shortly after Catalyst Biosciences closed its deal with Vertex, shareholders have come forward expressing that it was too little, too [...]
What Holds Back Diversity in Clinical Trials?
Despite an industry-wide push for diversity, equity, and inclusion efforts, clinical trials still suffer from a lack of diversity. Patient [...]
Pharma Climbs its Way Up the Fortune 500
This year’s Fortune 500 saw several pharmaceutical companies climbing the ranks, while some experienced exponential growth. Gilead, for example, grew [...]
Pharmaceutical Compliance Congress Canada 2022
Taking place in Toronto, ON from June 7-9, the Pharmaceutical Compliance Congress Canada is the leading conference in Canada for [...]
Bavarian Nordic in Talks with Governments to Produce Monkeypox Vaccines
As more cases of monkeypox spring up across the world, the German government has ordered 40,000 doses of monkeypox vaccines [...]
The Importance of Integrated Service Offerings in Biopharma
Smaller biotechs have pivoted in recent years from selling products early in the development cycle to holding onto their assets. [...]
Diabetes, Psoriasis, and Arthritis are Top Drug Categories for Ad Spending
Research from MediaRadar has identified diabetes as the largest therapy area for pharma direct-to-customer (DTC) advertising spending in 2021. Also [...]
European Medicines Agency Recommends Suspension of 100 Drugs Due to CRO Data Concerns
Data integrity issues at Synchron Research Services spurred the European Medicines Agency to recommend the suspension of 100 drugs. Synchron, [...]
Top Pharma Companies Form Coalition to Increase Access to Cancer Therapies in Developing Countries
Less than half of the cancer therapies deemed essential by the World Health Organization are available in low- and lower-middle-income [...]
Voluntary Recall Guidance Released by FDA
The US Food and Drug Administration (FDA) issued its final guidance in April on initiating voluntary recalls for drugs, biologics, [...]
Gilead Places Restrictions on 340B Drug Pricing for Hepatitis C Treatments
The drugmaker Gilead cut off 340B discounts for certain hepatitis C drugs to some hospitals if they do not provide [...]
Martin Shkreli Released Early; Transferred to Halfway House
Martin Shkreli, known as “Pharma Bro,” has been released from federal prison early. Shkreli, known for his smug demeanor, was [...]
Bridging the Innovation Gap with Biopharma Partnerships
With impending patent expirations and increased drug development times, the biopharma industry faces an innovation gap. Bridging this gap and [...]
Learning from Big Pharma to Optimize Psychedelic Drug Development
During a post-earnings conference call yesterday, May 17th, executives Atai Live Sciences N.V. explained what they’ve learned from Johnson & [...]
Roche and Bluebird Bio Reach Sickle Cell Gene Therapy Trademark Settlement
The trademark infringement lawsuit between Roche and Bluebird Bio has been settled. The case surrounded Bluebird’s “Be the Spark,” advertising [...]